The Bio Report
The Bio Report

The Race to Live Forever

Though the search for eternal youth has long been the fodder for myths and legends, science has been pushing us closer toward extending healthy years of life and has set some people off on efforts to defy death altogether. Peter Ward, in his new book The Price of Immortality: The Race to Live Foreve

Featured Speakers

Levine Media Group HostPeter Ward Guest

Topics Discussed

Episode Summary

Executive Summary: Peter Ward’s book explores the split between true immortality seekers and scientists working to extend healthspan. The discussion covers transhumanism, cryonics, mind uploading, aging biology, and why most realistic progress lies in preventing age-related decline rather than defeating death. Ward argues aging should be treated as a disease, but says practical longevity gains will likely come from complex prevention and lifestyle, not miracle cures.

Main Topics: Immortality vs. healthspan extension (Priority: 5/5): Ward distinguishes speculative quests for living forever from mainstream efforts to keep people healthier for longer, arguing the former is more ideological and less scientific. Transhumanism and its roots (Priority: 4/5): The conversation traces transhumanism from Fyodorov to Kurzweil, defining it as using technology to enhance humans and noting how modern transhumanists have repurposed older religious/philosophical ideas. Cryonics as a fallback strategy (Priority: 5/5): Cryonics is presented as plan B for immortality seekers: freezing the dead in hopes future technology can revive them, though the practice remains unproven and fragile as a business. Mind uploading and digital selves (Priority: 4/5): The episode examines theories of preserving personality through data or brain scans, but emphasizes the enormous scientific and philosophical problems around consciousness, identity, and continuity. Biology of aging and senescence (Priority: 5/5): Ward discusses hallmarks of aging, especially cellular senescence, highlighting that aging research is promising but complex and that interventions can have unintended effects. Diet, exercise, and practical longevity (Priority: 4/5): The strongest evidence for healthier longer life still points to common-sense habits like diet and exercise, with many high-tech approaches seen as overcomplicated or premature. Limits of human lifespan and regulation (Priority: 4/5): The episode closes on whether there is an upper bound to human life, with most researchers leaning toward around 120 years and noting the lack of regulatory pathways for aging therapies.

Key Arguments: Immortality is qualitatively different from healthspan extension: it is driven by a desire not to die and to personally experience the future, which makes it more speculative and less grounded in evidence. Immortality-seeking has a cultish or religious tone because human cultures have long mythologized eternal life, from Gilgamesh to Christianity. Transhumanism is a broad umbrella for human enhancement; modern adherents often strip away the spiritual and communal aspects of earlier thinkers like Fyodorov while keeping the immortality goal. Cryonics is a long-shot backup plan rather than a proven therapy; it aims to preserve the brain/body after death, but no one has been revived and the business is operationally risky. Mind uploading is theoretically imaginable through behavioral data or brain scanning, but current technology is nowhere close and may only create a copy rather than preserve consciousness. Aging biology is underfunded relative to its importance, and treating aging as a root disease could reduce multiple age-related illnesses more effectively than attacking each disease separately. Senescent cells are not simply harmful waste; they also help prevent cancer and other damage, showing why anti-aging interventions can backfire. The most reliable longevity advice remains conventional: healthy diet, exercise, and preventative medicine, not expensive experimental interventions. Most experts interviewed believe the human lifespan likely has a limit around 120 years, though a minority think someone who will reach 150 may already have been born.

Data Points: Cryonics patients at Alcor: around 190 - Ward cites Alcor as the largest cryonics practitioner. Estimated cryonics cases worldwide: less than 1,000 - Ward says total global numbers are difficult to verify but are likely under 1,000. Cryonics industry age: about 50 years - He describes cryonics as a fledgling industry for roughly half a century. Mouse brain mapping progress: a tiny slither of a mouse brain took months - Used to illustrate how far brain scanning is from mind uploading. Study on curing cancer and heart disease: around 3 years added life expectancy - Ward cites a 1990s study suggesting limited gains if only these diseases were cured. Expected lifespan limit: around 120 years - Most gerontologists Ward interviewed believe human lifespan has an upper limit near this age. Space study reference: telomeres got longer in astronauts - Mentioned as a comparison, later attributed to regimented diet and exercise rather than space itself.

Pivotal Quotes: "the pursuit of immortality or even radically extended life is on the whole, I think, a slightly more selfish goal" — Peter Ward: Ward contrasts immortality seekers with researchers focused on healthier aging. "it's better than being in the control group" — Peter Ward: He explains the cryonics community’s rationale for freezing bodies despite low odds. "we should use technology to enhance the human condition in any way possible" — Peter Ward: Ward defines transhumanism and situates immortality within it.

Implications: For listeners and the industry, the episode argues for skepticism toward immortality hype and support for aging research, especially prevention, biomarkers, and healthy behavior. Real gains will likely be incremental, regulated, and biologically complex rather than radical.

🔓 Sign Up for Unlimited Episode Search

About The Bio Report

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

View all episodes from The Bio Report